Viewing Study NCT00004635


Ignite Creation Date: 2025-12-24 @ 10:12 PM
Ignite Modification Date: 2026-01-27 @ 5:21 PM
Study NCT ID: NCT00004635
Status: COMPLETED
Last Update Posted: 2018-05-22
First Post: 2000-02-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: 000080
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None UNKNOWN View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None FED View
None OTHER View